novo nordisk's semaglutide failed to slow alzheimer's disease progression fails of in highly anticipated trials, Nordisk says Novo Nordisk Alzheimer's drug trials

Walsh, A.C., J.A

Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for good PRINCETON, NJ June, 24 2026 Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider

These results provide the first evidence that inhibiting the PI3K/Akt pathway attenuates CM-associated allodynia

Bottom line: Most body aches associated with GLP-1 use are preventable or manageable through proactive hydration, high protein intake, and consistent movement

Even if the vial has been stored correctly, expired medication may not work as expected